Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GNAO1 | P09471 | 7/20 | 0.41 |
| ▸ | GNAI3 | P08754 | 6/20 | 0.40 |
| ▸ | GNAI1 | P63096 | 6/20 | 0.40 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.39 |
| ▸ | ALB | P02768 | 1/20 | 0.38 |
| ▸ | ACHE | P22303 | 1/20 | 0.38 |
| ▸ | MAOB | P27338 | 1/20 | 0.38 |
| ▸ | HRH1 | P35367 | 1/20 | 0.37 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.36 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.36 |
| ▸ | CHRM5 | P08912 | 1/20 | 0.36 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.36 |
| ▸ | DRD2 | P14416 | 1/20 | 0.36 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.36 |
| ▸ | DRD4 | P21917 | 1/20 | 0.36 |
| ▸ | DRD3 | P35462 | 1/20 | 0.36 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.35 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29244364 | 0.92 | GNAO1 (0.46) | GNAO1GNAI3GNAI1KCNH2MAOB | |
| SCHEMBL2116543 | 0.88 | HTR1A (0.38) | GNAO1GNAI3GNAI1KCNH2ALB | |
| SCHEMBL218251 | 0.87 | SLC18A3 (0.44) | GNAO1GNAI3GNAI1KCNH2HRH1 | |
| SCHEMBL23828683 | 0.87 | GNAO1 (0.46) | GNAO1GNAI3GNAI1KCNH2 | |
| SCHEMBL3424498 | 0.83 | ACHE (0.44) | GNAO1ALBACHEMAOBCHRM2 | |
| SCHEMBL14380838 | 0.83 | GNAO1 (0.52) | GNAO1GNAI3GNAI1KCNH2EPHX1 | |
| SCHEMBL2148991 | 0.82 | GNAO1 (0.53) | GNAO1GNAI3GNAI1KCNH2HRH1 | |
| SCHEMBL15223935 | 0.81 | HTR1A (0.43) | KCNH2HRH1CHRM2DRD2DRD4 | |
| SCHEMBL24753348 | 0.81 | GNAO1 (0.60) | GNAO1GNAI3GNAI1KCNH2DRD4 | |
| SCHEMBL3424285 | 0.81 | ACHE (0.48) | GNAO1KCNH2ALBACHEMAOB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8158652-B2 | 1-Difluoromethyl-5-{4-[3-(1-piperidinyl)propoxy]phenyl}-2(1H)-pyridone; compounds act as histamine-H3 receptor antagonistic substances or inverse-agonistic substances; useful as preventives or remedies for various circular system diseases, nervous system diseases, metabolic system diseases | MSD K.K. (JP) | 2012-04-17 | — | — | US | disclosed |
| US-20080269287-A1 | Substituted Pyridone Derivative | MSD K.K. (JP) | 2008-10-30 | — | — | US | disclosed |
| EP-1820797-A1 | SUBSTITUTED PYRIDONE DERIVATIVE | BANYU PHARMACEUTICAL CO., LTD. (JP) | 2007-08-22 | — | — | EP | disclosed |
| CN-1750824-A | 4- [ (2, 4-dichloro-5-methoxyphenyl) amino ] -6-alkoxy-3-cyanoquinolines for the treatment of ischemic injury | WYETH CORP (US) | 2006-03-22 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080269287-A1 | Substituted Pyridone Derivative | HRH3, HRH4, HRH1 | GNAO1 2673/4885GNAI3 3293/4885GNAI1 2800/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.